Cleave Biosciences Inc. logo

Cleave Biosciences Inc.

Cleave Biosciences is a biopharmaceutical company pioneering the development of novel protein homeostasis inhibitors for the treatment of cancer. Cleave’s lead drug development candidate is CB-5083 a potent, oral, selective, first-in-class inhibitor of p97.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.cleavebio.com/
Disease Focus
STOCK CODENon Listed
Address
866 Malcolm, Suite 100Burlingame, CA 94010United States
Burlingame
United States
Email
Contact Number
16504433000